Abstract:ABSTRACT Metabolic syndrome (MetS) represents a cluster of major risk factors known to be associated with the development of aging-related diseases, such as cardiovascular disease and diabetes. Telomere length (TL) is often used as a cellular marker for biological age. Shorter TL indicates increased biological age. It is unknown whether maintenance of a short TL could be predictive for onset of metabolic diseases associated with increasing biological age. A number of studies found significant associations between shorter TL and dysregulated MetS components, but other studies did not confirm this finding. This cohort study investigated the relationship between shorter baseline TL and a worse metabolic profile with less favorable trajectories of MetS components over a 6-year follow-up. Participants included 2842 men and women aged 18 to 65 years who were part of The Netherlands Study of Depression and Anxiety, an ongoing prospective cohort study with 6-year follow-up. Telomere length from leukocytes was determined using quantitative polymerase chain reaction. Metabolic syndrome components (waist circumference, triglycerides, high-density lipoprotein &lsqb;HDL&rsqb;, cholesterol, fasting glucose, and systolic and diastolic blood pressure) were determined at baseline and after 2 and 6 years. Adjustments were made at baseline and 2- and 6-year follow-up for covariates (sociodemographic, lifestyle, and health factors) that could affect cross-sectional and longitudinal analyses. Shorter TL was cross-sectionally associated with a higher number of MetS abnormalities (&bgr; = 0.075, SE = 0.023, P = 0.001), higher waist circumference (&bgr; = 0.647, SE = 0.238, P = 0.007), triglycerides (&bgr; = .038, SE = 0.009, P < 0.001), and fasting glucose (&bgr; = 0.011, SE = 0.003, P < 0.001), and with lower HDL cholesterol (&bgr; = − 0.016, SE = 0.008, P = 0.05). No consistent patterns of association between TL and hypertension were found. Baseline differences progressively diminished over time; however, shorter baseline TL was still significantly associated with a worse level for most MetS components at both the 2- or 6-year follow-up. These findings show that cellular aging, as assessed by TL, is associated with a higher number of MetS abnormalities (representing a more severe metabolic risk profile) that persists even after a period of 6 years. The data suggest that a shorter TL could be predictive for the onset of various aging-related somatic diseases through its effect on metabolic alterations.

Telomere length as a biomarker in multiple sclerosis

Leukocyte telomere length in multiple sclerosis: relationship between disability severity and pregnancy history

Leukocyte Telomere Length Predicts Severe Disability in Relapsing-Remitting Multiple Sclerosis and Correlates with Mitochondrial DNA Copy Number

Accelerated Leukocyte Telomere Erosion in Schizophrenia: Evidence from the Present Study and a Meta-Analysis

Leukocyte Telomere Length is Associated with Disability Progression in Multiple Sclerosis Independent of Chronological Age

A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study

Longer Leukocytes Telomere Length Predicts a Significant Survival Advantage in the Elderly TRELONG Cohort, with Short Physical Performance Battery Score and Years of Education as Main Determinants for Telomere Elongation

Telomere length and brain imaging phenotypes in UK Biobank

Association between telomere length and neuropsychological function at 4–5 years in children from the INMA project: a cross-sectional study

Telomere length and 4-year changes in cognitive function in an older Mediterranean population at high risk of cardiovascular disease

Association of telomeres length with cardiovascular risk factors and arterial stiffness

Leukocyte telomere length: Effects of schizophrenia, age, and gender

Leucocyte telomere length, brain volume and risk of dementia: a prospective cohort study

Telomere shortening in late‐life depression: A potential marker of depression severity

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Association of Telomere Length in T Lymphocytes, B Lymphocytes, NK Cells and Monocytes with Different Forms of Age-Related Macular Degeneration

Leukocyte telomere length and memory circuitry and cognition in early aging: Impact of sex and menopausal status

Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome

Leukocyte telomere length and attrition in association with disease severity in cystic fibrosis patients

Association Between The Length Of Leukocyte Telomeres And Functional Performance Of Older Adults: Observational Study

Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study